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ABSTRACT
A growing number of tissue-specific inherited disorders are
associated with impaired ribosome production, despite the
universal requirement for ribosome function. Recently, mutations in
RPSA, a protein component of the small ribosomal subunit, were
discovered to underlie approximately half of all isolated congenital
asplenia cases. However, the mechanisms by which mutations in this
ribosome biogenesis factor lead specifically to spleen agenesis
remain unknown, in part due to the lack of a suitable animal model for
study. Here we reveal that RPSA is required for normal spleen
development in the frog, Xenopus tropicalis. Depletion of Rpsa in
early embryonic development disrupts pre-rRNA processing and
ribosome biogenesis, and impairs expression of the key spleen
patterning genes nkx2-5, bapx1 and pod1 in the spleen anlage.
Importantly, we also show that whereas injection of human RPSA
mRNA can rescue both pre-rRNA processing and spleen patterning,
injection of human mRNA bearing a common disease-associated
mutation cannot. Together, we present the first animal model of
RPSA-mediated asplenia and reveal a crucial requirement for RPSA
in pre-rRNA processing and molecular patterning during early
Xenopus development.
KEY WORDS: Asplenia, RPSA, Ribosomopathy, Xenopus,
rRNA processing
INTRODUCTION
As the molecular machines responsible for producing proteins,
ribosomes are ubiquitously essential for life. Indeed, a single
mammalian cell can contain 10 million individual ribosomes and
devote 70% of total cellular transcription to ribosome production
(Freed et al., 2010; Warner et al., 2001). Ribosome biogenesis is an
extraordinarily complex process that occurs in multiple cellular
compartments and requires the coordinated action of more than 200
distinct ribosome biogenesis factors, all three RNA polymerases
and 75 small nucleolar RNAs (Armistead and Triggs-Raine, 2014;
Freed et al., 2010; Gallagher et al., 2004; Granneman and Baserga,
2004; Henras et al., 2008;Woolford and Baserga, 2013). Production
starts in the nucleolus, with transcription of pre-ribosomal RNAs
(pre-rRNA), and continues through a series of carefully regulated
cleavages and ribonucleoparticle assembly steps to ultimately
produce the large 60S ribonucleoprotein subunit (LSU, an
intricate complex of 46 ribosomal proteins and the 28S, 5.8S and
5S rRNAs) and the small 40S subunit (SSU, 33 ribosomal proteins
and the 18S rRNA) (Armistead and Triggs-Raine, 2014; Henras
et al., 2008; Sondalle and Baserga, 2014). Along with cytoplasmic
translation factors, the LSU and SSU form a functional ribosome.
It is not surprising that defects in ribosome production or function
are detrimental to health. Indeed, mutations that affect ribosome
biogenesis have now been identified in numerous human congenital
disorders (ribosomopathies) and multiple animal models are
available for study (Armistead et al., 2009; Armistead and Triggs-
Raine, 2014; Boocock et al., 2003; Dauwerse et al., 2011; Devlin
et al., 2010; Dixon et al., 1997; Ebert et al., 2008; McGowan et al.,
2008; Mirabello et al., 2017, 2014; Nousbeck et al., 2008; Uechi
et al., 2008; Wilkins et al., 2013; Zhao et al., 2014). However, these
mutations produce an intriguingly heterogeneous collection of
clinical phenotypes that are surprisingly tissue specific given the
ubiquitous requirement for ribosomes. For example, inherited
mutations in any of at least 19 proteins, many of them ribosomal,
cause Diamond-Blackfan anemia, which is associated with bone
marrow failure, craniofacial, limb and growth defects (Boria et al.,
2010; Farrar et al., 2014; Gazda et al., 2012, 2008; Landowski
et al., 2013; Mirabello et al., 2017; Wang et al., 2015). TCOF1
mutations are primarily associated with craniofacial abnormalities
(Treacher-Collins syndrome) (Dixon et al., 1997, 2006; Sondalle
and Baserga, 2014), whereas mutations in another ribosome
biogenesis factor, UTP4, cause North American Indian childhood
cirrhosis, a specific childhood liver failure syndrome (Chagnon
et al., 2002; Freed and Baserga, 2010). Ribosomopathies are,
therefore, clinically distinct and difficult to treat (Armistead and
Triggs-Raine, 2014; Danilova and Gazda, 2015). Investigating the
etiology of these tissue-specific phenotypes will transform our
understanding of ribosomopathies and provide a crucial step
towards improving diagnosis and treatment.
Isolated congenital asplenia (ICA, OMIM #271400) is a rare and
often fatal developmental anomaly, which has recently been
identified as a ribosomopathy (Bolze et al., 2013). Characterized by
the absence or severe hypoplasia of the spleen at birth in otherwise
healthy individuals, ICA is a form of primary immunodeficiency that
leaves patients susceptible to bacterial infections (Gilbert et al., 2002;
Lindor et al., 1995; Mahlaoui et al., 2011). While antibiotic
prophylaxis can decrease mortality, ICA often goes undiagnosed
because of the absence of an external phenotype and patients
typically succumb to sepsis in early childhood.Received 11 April 2018; Accepted 13 September 2018
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Spleen development remains poorly understood. Studies in humans
and in animal models demonstrate that the spleen anlage forms as a
condensation of mesenchymal progenitor cells within the left dorsal
mesogastrium (Brendolan et al., 2007; Patterson et al., 2000; Sty and
Conway, 1985; Vellguth et al., 1985). These progenitors proliferate
and interact with contributing endothelial and hematopoietic cells
to ultimately produce a functional spleen. Previous work has revealed
a gene regulatory network, including Nkx2-5, Bapx1 (also known
as Nkx3-2), Pbx1,Hox11 (also known as Tlx1) and Pod1 (also known
as Tcf21), that regulates this process (Brendolan et al., 2005; Burn
et al., 2008; Herzer et al., 1999; Koss et al., 2012; Lettice et al., 1999;
Lu et al., 2000; Pabst et al., 1999; Patterson et al., 2000; Roberts et al.,
1994). While laterality defects can also produce syndromic forms of
asplenia (Burton et al., 2014; Kothari, 2014), ICA is considered to be
distinct, as it occurs in isolation.
Multiple heterozygous mutations in the ribosomal SSU protein
RPSA have been identified in ICA patients, although the penetrance
appears incomplete (Bolze et al., 2018, 2013). RPSA is a highly
conserved protein that is required for protein synthesis and
maturation of the 18S rRNA component of the 40S subunit (Auth
and Brawerman, 1992; Malygin et al., 2011; Nelson et al., 2008;
O’Donohue et al., 2010). In vertebrates the C-terminal region of
RPSA has evolved an additional role as a receptor for laminin
(Ardini et al., 1998; Lesot et al., 1983; Nelson et al., 2008; Rao
et al., 1983; Terranova et al., 1983). Interestingly, no pre-rRNA
processing defects were detected in activated lymphocytes from
ICA patients, and heterozygous null RPSA mutant mice do not
exhibit asplenia (Bolze et al., 2013). Thus, the mechanisms by
which mutations in RPSA lead to spleen agenesis remain undefined,
and there has been no animal model of the human disease.
Here we reveal that rpsa is required for normal spleen
development in the frog, Xenopus tropicalis. Depletion of Rpsa
disrupts pre-rRNA processing and ribosome biogenesis, and
impairs expression of the key spleen patterning genes nkx2-5,
pbx1 and pod1 in the spleen anlage. Importantly, we also show that
whereas injection of human RPSA mRNA can rescue both pre-
rRNA processing and spleen patterning, mRNA containing the most
common disease mutation cannot. Altogether, we present the first
animal model of RPSA-mediated asplenia and reveal a crucial
requirement for RPSA in pre-rRNA processing and molecular
patterning of the spleen during vertebrate development.
RESULTS AND DISCUSSION
Expression of rpsa is dynamically regulated during
development
As an initial step in our investigation, we examined rpsa mRNA
expression during X. tropicalis embryogenesis. Despite a global
requirement for ribosome biogenesis, we observed tissue-specific
enrichment of rpsa transcripts. No rpsa expression was detectable by
in situ hybridization of labeled antisense probes at pregastrulation
stages (Fig. 1A), suggesting that Xenopus embryos do not inherit
large amounts of maternal rpsa mRNA. At stage 16, expression
was strongly detected throughout the developing neural folds.
Transcripts were robustly detected in posterior regions of the
neural tube at stage 24, but appeared relatively weak within
anterior regions and the brain. Expression of rpsawas also evident
in migrating neural crest at this stage (Fig. 1A). This association of
rpsa expression with the developing neural tube, brain, neural crest
and intersomitic spaces was maintained at stage 28. Importantly,
expression was also diffusely detected in the anterior lateral
mesoderm from which the spleen forms, and within the ventral
blood islands and mesoderm (Fig. 1A).
To quantitatively analyze embryonic rpsa expression dynamics,
we used our previously published ultra-high temporal resolution
RNA-seq data set (Owens et al., 2016). This resource allows precise
measurement of absolute transcripts per embryo and visualization of
transcript kinetics for the entire transcriptome during Xenopus
development. Consistent with our in situ results, these quantitative
data revealed extremely low levels of rpsa prior to gastrulation and a
steady increase in transcription from neurulation onwards (Fig. 1B).
Spleen development is impaired in rpsa morphants
We used translation (rpsaATG) and splice (rpsaSplice) blocking
morpholino oligonucleotides (MO) to deplete Rpsa and investigate
its requirements in development. With the exception of a mild
reduction in anterior-posterior length, rpsa morphants appear
comparable with controls at stage 45 (Fig. S1A) and are able to
swim and feed normally. However, morphants fail to increase in size
and become significantly less active post stage 45. By stage 48, 50%
of morphants develop a mild edema, and all die within 12 days of
fertilization. Addition of gentamycin failed to improve survival,
which suggested that infection is not a major cause of death.
As late stage lethality prevented direct examination of adult
spleen anatomy, we instead assayed the expression of crucial splenic
genes at earlier stages of development. The transcription factors that
are encoded by the genes bapx1, nkx2-5 and pod1 are essential for
spleen formation (Brendolan et al., 2007; Koss et al., 2012; Lettice
Fig. 1. rpsa is dynamically expressed in development. (A,B) Both in situ
hybridization (A) and ultra-high temporal resolution RNA-seq analysis
(B) reveal low levels of rpsa transcripts prior to stage 12 in X. tropicalis.
Expression increases throughout subsequent stages and is primarily
associated with the developing neural folds (nf), brain (b), cranial neural crest
(cnc) and ventral mesoderm/blood islands (vm/bl). Expression is also diffusely
detected in the lateral mesoderm (lm) where the spleen will form. pa,
pharyngeal arches.
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et al., 1999; Lu et al., 2000; Patterson et al., 2000; Quaggin et al.,
1999). Indeed, in human ICA patients, homozygous missense
mutations in NKX2-5 have been identified (Koss et al., 2012).
Knockdown of Rpsa results in severe reduction or loss of nkx2-5,
bapx1 and pod1 expression in the developing spleen of stage 38
embryos, whereas expression remains relatively unaltered in other
regions (Fig. 2, Fig. S2). Importantly, this phenotype persisted at
later stages of development (stage 40, Fig. S2B), revealing that it is
not caused by a developmental delay. Together, these observations
demonstrate that rpsa is required for early spleen formation in
Xenopus. As 2 ng and 4 ng of rpsa MO produced a similar nkx2-5
phenotype (Fig. 2), we injected 2 ng in all subsequent experiments.
As human mutations in RPSA cause ICA, we further investigated
the specificity of the phenotype by examining the development of
other structures. Formation of the craniofacial cartilages, eyes, heart
and gut appeared grossly normal in stage 45morphants (Fig. S1A,B).
We noted that nkx2-5 expression is relatively unaffected in its cardiac
domain, despite being lost in the spleen of rpsa morphants at stages
38 and 40 (Fig. 2, Fig. 3, Fig. S2). Expression of the gene encoding
the transcription factor Nkx2-1 also appeared normal in the
developing lungs, forebrain and olfactory region of morphants at
stage 38 (Fig. S1C). Expression of hex (a key regulator of endoderm
organogenesis) and pax2 (in the brain, otic placode and kidney) were
similarly unaffected by Rpsa depletion at this stage (Fig. S1C). As
congenital asplenia is commonly associated with laterality
syndromes, we also examined expression of pitx2c, a key
asymmetrically expressed gene in left-right development. No
evidence of a laterality defect was detected in stage 28 morphants
(Fig. S1D). Together, these results demonstrate that Rpsa depletion is
affecting spleen patterning in the early embryo, recapitulating the core
of the human patient phenotype.
A human disease mutation disrupts RPSA function
in Xenopus
In ICA patients a recurrent missense mutation, R180G, was
identified (Bolze et al., 2013). This position is highly conserved
(Ardini et al., 1998) (Fig. S3A); however, whether the patient
allele is deleterious was previously undefined. Therefore, we first
examined the structure of RPSA from a cryo-electron microscopy
(cryo-EM) reconstruction of the 80S human ribosome to determine
the molecular consequences of the R180G mutation. Our structural
analysis revealed that arginine 180 (R180) in RPSA has predicted
polar contacts with glutamate 181 (E181) and aspartate 14 (D14)
(Fig. S3B). Mutation of residue 180 to glycine (R180G) is predicted
to abolish these interactions, likely destabilizing the protein’s
tertiary structure (Fig. S3C).
To test this functionally, we examined this variant using our
Xenopus model. Importantly, co-injection of full-length human
RPSA mRNA rescued expression of both nkx2-5 and bapx1 in the
spleen of morphants at stage 38 (Fig. 3, Fig. S2), demonstrating
the specificity of our MO-mediated knockdown strategy. Injection
of human mRNA carrying the R180G mutation was unable to
rescue expression of either gene (Fig. 3, Fig. S2), suggesting that
the disease mutation impairs the RPSA function required for spleen
development.
Pre-rRNA processing is impaired in rpsa morphants
RPSA has previously been implicated in late maturation of the 18S
rRNA in cell culture (O’Donohue et al., 2010). Using an antisense
oligonucleotide probe targeting the internal transcribed spacer
(ITS1) of X. tropicalis (probe c, Fig. 4A), we investigated the
Fig. 2. Depletion of Rpsa using either a translation (RpsaATG) or splice
(RpsaSplice) blocking morpholino impairs expression of nkx2-5 and
bapx1 in the spleen of stage 38 rpsamorphants. (A) Representative images
of the expression phenotype. Middle and right panels are magnifications
of the spleen region marked by a box in the left panel. Black arrowheads
indicate normal expression. Blue arrowheads indicate reduced expression.
Red arrowheads indicate lack of expression. (B) The percentage of embryos
with reduced or absent nkx2-5 or bapx1 expression in the developing spleen
following rpsa depletion. ***P≤0.0001 (two-tailed Fisher’s exact test).
Fig. 3. The human R180G mutation is detrimental to function.
(A) Representative images of nkx2-5 expression in the spleen anlage of
stage 38 embryos. Depletion of Rpsa causes a severe reduction of nkx2-5
expression, which can be ameliorated by injection of humanWT RPSA mRNA
but not by injection of R180G mutated mRNA. Green arrowheads highlight
robust expression; red arrowheads indicate reduced expression. (B,C) The
percentage of embryos with reduced or absent nkx2-5 (B) or bapx1 (C)
expression. **P<0.001, ***P<0.0001 (two-tailed Fisher’s exact test). CMO,
control morpholino; rpsaATG, translation-blocking MO; NS, not significant;
UC, uninjected control.
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requirement for rpsa in pre-rRNA processing during vertebrate
development. Probe c revealed an accumulation of the 18.5S and
19S pre-rRNAs in stage 38 morphants, consistent with a defect in
later maturation steps of the 18S rRNA (Fig. 4B, lane 3, and 4C,D).
Unexpectedly, Rpsa depletion also caused a striking reduction in
36S pre-rRNA levels (Fig. 4B, lane 3, and 4C,D). The reduced
levels of the 36S pre-rRNAs, concomitant with the accumulation of
the 18.5S and 19S pre-rRNAs, are consistent with a requirement
for Rpsa in pre-rRNA cleavage at site 2 (Fig. 4A). Therefore, our
results demonstrate a crucial requirement for Rpsa in embryonic 18S
rRNA biogenesis and reveal a role for Rpsa in production of the 36S
pre-rRNA (Fig. 4).
To confirm that these cleavage defects were specific to Rpsa
depletion, we co-injected the human RPSAmRNA, which rescued all
the processing defects that were observed in rpsamorphants (Fig. 4B,
lane 4, and 4C). Conversely, injection of the R180G ICA mutant
mRNA did not rescue pre-rRNA processing (Fig. 4B, lane 5, and 4C,
D). Together, these data confirm that RPSA has an evolutionarily
conserved function in ribosome biogenesis during development,
which is disrupted by the R180G ICA disease mutation.
RPSA has dual functions in the cell. Its highly conserved
N-terminal region plays a critical role in formation of the 40S SSU,
while its C-terminal region has evolved a relatively new role as a
receptor for laminin (Ardini et al., 1998; Auth and Brawerman,
1992; Lesot et al., 1983; Malygin et al., 2011; Nelson et al., 2008;
O’Donohue et al., 2010; Rao et al., 1983; Terranova et al., 1983).
Thus, the precise mechanism through which mutations in RPSA
cause ICA remains undefined. However, while Bolze et al. failed to
detect pre-rRNA processing defects in ICA patient lymphocytes,
three of the seven identified patient mutations occurred in regions of
the RPSA N-terminus that are associated exclusively with ribosome
biogenesis (Ardini et al., 1998; Bolze et al., 2013). Furthermore, all
of the identified mutations, including R180G, affected residues
that are conserved from mammals to lower eukaryotes, such as
Saccharomyces cerevisiae and Neurospora crassa, which predate
the advent of laminin receptor function, suggesting that RPSA’s
ribosomal function is essential to spleen development. Our
observation that human RPSA mRNA can rescue both pre-rRNA
processing and spleen patterning, whereas the R180G disease
mutation cannot, demonstrates that the human mutation disrupts a
ribosomal function of RPSA and supports the hypothesis that
impaired ribosome production underlies ICA.
How mutations in the ubiquitous production of ribosomes lead to
tissue-specific phenotypes, such as spleen agenesis, remains an
Fig. 4. Rpsa is required for pre-rRNA processing.
(A) Diagram of pre-rRNA processing pathways
in X. tropicalis. The primary transcript pre-rRNA
undergoes several nucleolytic cleavages to produce
the mature 18S, 5.8S and 28S rRNAs. c (red),
position of the northern blot probe; ETS, external
transcribed spacers; vertical lines indicate cleavage
sites. (B-D) Depletion of Rpsa causes pre-rRNA
processing defects that are rescued by WT human
RPSA (hRPSA) but not by ICA-mutated RPSA
mRNA (R180G). Stage 38 X. tropicalis pre-rRNAs
isolated from pools of 10-15 whole embryos were
detected by northern blotting (B). The 7SL RNA
was used as a loading control. +, injection; −, no
injection. (C) RAMP quantitation of the ratios of
pre-rRNAs relative to each other. (D) RAMP
quantitation of the pre-rRNAs relative to the 7SL
loading control. Data are mean+s.d. for four
independent biological replicates. **P≤0.01,
***P≤0.001, ****P≤0.0001 (two-way ANOVA with
Tukey’s multiple comparisons test). CMO, control
morpholino; rpsaATG, translation-blocking MO;
UC, uninjected control.
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intriguing issue. One possibility is that particular cell populations
are more sensitive to reduced rates of mRNA translation (Green
et al., 2000). The cranial neural crest, for example, is particularly
sensitive to impaired ribosome production and depletion of several
distinct ribosome biogenesis factors can trigger P53-mediated cell
death (Amsterdam et al., 2004; Calo et al., 2018; Dixon et al., 2006;
Griffin et al., 2015; Hölzel et al., 2010; Jones et al., 2008; Valdez
et al., 2004; Wilkins et al., 2013; Zhao et al., 2014). However,
this sensitivity alone seems unlikely to explain the distinct tissue-
specific phenotypes of ribosomopathies. For example, why are
such cranial neural crest malformations not observed in all
ribosomopathies? Or why does the bone marrow failure that
characterizes Diamond Blackfan anemia not occur in Treacher
Collins syndrome? Another possible explanation is that ribosomes
may be ‘specialized’ to have unique properties or preferentially
translate particular mRNAs in diverse cell populations. Indeed,
support for the specialized ribosome hypothesis has been growing,
with observations of tissue-specific differences in ribosomal protein
expression (Bortoluzzi et al., 2001; Green et al., 2000; Robson et al.,
2016; Sahin et al., 2005; Wong et al., 2014; Zhao et al., 2014), and
context-dependent selective mRNA translation by particular
ribosomal proteins (Dinman, 2016; Ferretti et al., 2017; Horos
et al., 2012; Kondrashov et al., 2011; McCann and Baserga, 2013;
Segev and Gerst, 2018; Shi and Barna, 2015; Shi et al., 2017;
Xue and Barna, 2012). Our study reveals that Rpsa depletion
preferentially affects early patterning of the spleen, and places
rpsa upstream of the known genetic network that regulates spleen
formation. However, it remains for future studies to determine
whether this loss of patterning occurs through reduced translation of
spleen regulatory mRNAs, increased local cell death or a currently
unknown mechanism.
It is important to note that rpsamorphants have additional defects
at later stages of development and, as such, the asplenia does not
occur in isolation in our model. These additional phenotypes most
likely reflect the level of Rpsa knockdown present in morphants.
Rpsa is required in all cells and the degree of developmental defect
appears to reflect dose. For example, Rpsa null mice die at E3.5,
whereas heterozygotes are completely normal. Most human patients
carrying deleterious heterozygous mutations develop ICA (Bolze
et al., 2018, 2013). Our morphants most likely have an intermediate
reduction in Rpsa levels that results in additional defects at later
stages of development. However, reduced expression of three genes
that are required for spleen formation in rpsa morphants, together
with normal embryonic morphology and unaffected expression of
non-spleen genes, supports the hypothesis that the spleen is
particularly sensitive to reduced levels of RPSA.
In this study, we have investigated Rpsa requirements in spleen
development. We present the first animal model of Rpsa-mediated
asplenia and demonstrate an evolutionarily conserved requirement
for rpsa in pre-rRNA processing and molecular specification of the
spleen during embryogenesis. The genetic regulation of spleen
development and the causes of spleen anomalies, ICA in particular,
have long remained unclear. Initial attempts to study the mechanism
of RPSA-mediated asplenia have been hampered by the lack of an
appropriate animal model (heterozygous null Rpsa mice develop
normal spleens, while homozygous null mutants die in early
development) (Bolze et al., 2013). Furthermore, although mouse
models have sometimes been informative in the study of
ribosomopathies, the phenotype is often very sensitive to genetic
background, which complicates analysis (Dixon et al., 2006; Jones
et al., 2008). Here, we used MOs, which allow for efficient and
tractable protein depletion, to produce a novel animal model of
RPSA-mediated asplenia. Our work places rpsa in the gene
regulatory network that orchestrates spleen development, identifies
its function in pre-rRNA processing and supports a role for impaired
ribosome biogenesis in the pathogenesis of ICA. We highlight the
utility of Xenopus as a model in which to study ribosomopathies
and believe that this approach holds value for future studies of
human asplenia.
MATERIALS AND METHODS
Xenopus
X. tropicalis were maintained and cared for in our aquatics facility, in
accordance with Yale University Institutional Animal Care and Use
Committee protocols. Embryos were produced and raised to appropriate
stages as previously described (del Viso and Khokha, 2012).
Antisense morpholino knockdown and RNA rescue
Antisense MOs targeting the rpsa translational start site (5′-CCGGAC-
ATTGTGAGTTACCCCTTT-3′) or standard control morpholinos (CMO)
were obtained from Gene Tools and injected at the one-cell stage. A full-
length human RPSA cDNA was obtained from the hORFeome v8.1 library
from the Center for Cancer Systems Biology at Dana-Farber Cancer Institute
(HsCD00508936) and subcloned into the pCSDest2 vector using Gateway
recombination techniques (Invitrogen). A human R180G RPSA clone was
synthesized using the GeneArt strings DNA fragment service of Life
Technologies. Capped mRNAs were generated in vitro using the mMessage
machine kit (Ambion) according to the manufacturer’s instructions.
In situ hybridization
Digoxigenin-labeled antisense probes for rpsa (TNeu119p20; Genbank:
NM_203737.1), pitx2c (TNeu083k20; Genbank: CR760278.2), hex
(TGas075h17; Genbank: CR761571.2) and pax2 (TNeu062i10;
GenBank: CR760264.2) were in vitro transcribed with T7 High Yield
RNA Synthesis Kit (E2040S, New England Biolabs). A bapx1 fragment for
probe synthesis was produced by PCR (primers 5′-TTGGGATCCATTT-
GGGGAGC-3′ and 5′-TGGTGGTTGA- AGCGTCTCTC-3′) and cloned in
pCS108. Embryos were fixed in MEMFA (10% 10× MEMFA salt, 10%
formaldehyde, 80% water) for 1-2 h at room temperature and dehydrated
into 100% ETOH. Whole-mount in situ hybridization was performed as
described previously (Khokha et al., 2002).
Northern blotting
Pools of ten to 15 embryos were dissolved in TRIzol (Invitrogen) and total
RNA was extracted as per the manufacturer’s instructions. Northern blot
analyses were performed as described previously (Pestov et al., 2008). Then
2 μg or 4 μg of total RNA per sample were separated by gel electrophoresis
on a 1% agarose/1.25% formaldehyde gel and then transferred to a nylon
membrane (Hybond-XL, GE Healthcare). RNA species were detected by
hybridization with a radiolabeled oligonucleotide probe. Oligonucleotide
probes were: Probe c, 5′-CAGGTACCCGGGTCGGCCTGCGGCG-3′;
7SL: 5′-CATA- TTGATACCGAACTTAGTGC-3′.
Imaging
Images were taken using a Canon DS126201 camera and Zeiss Discovery
V8 SteREO microscope. Optical coherence tomography of the craniofacial
cartilages was carried out as previously described (Deniz et al., 2017).
Structural modeling
All structural models of RPSA were generated from a cryo-EM structure of
the human 80S ribosome (Protein Data Bank ID: 4UG0) (Khatter et al.,
2015) using the PyMOL Molecular Graphics System, version 2.0.6
(Schrödinger). Identification of polar interactions and modeling of
mutated residues were also performed using PyMOL.
Quantification and statistical analysis
Each experiment was repeated a minimum of three times. Statistical
significance is reported in the figures and legends and was defined as P<0.05
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(*P<0.01, **P<0.001 and ***P<0.0001). In Figs 2, 3 and Fig. S2 the in situ
hybridization results were analyzed using a two-tailed Fisher’s exact test. In
Fig. 4, a phosphorimager (Bio-Rad Personal Molecular Imager) was used to
quantify northern blots. Ratio analysis of multiple precursors (RAMP) was
performed as described in Wang et al. (2014) and a two-way ANOVAwith
Tukey’s multiple comparisons test for post hoc analysis was used to
determine statistical significance.
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